Clinical Trial Update: Use of Long-acting Bupivacaine In Lower Extremity Amputation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating long-acting bupivacaine for pain management after lower extremity amputation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amputation
• Anesthesia Local
• Opioid Use

Drugs mentioned

• long-acting bupivacaine (bupivacaine)

Snippet

Sponsor: Loma Linda University | Conditions: Amputation, Anesthesia, Local | Phase 4 | Status: TERMINATED